Generic Name and Formulations:
Diphenhydramine HCl 25mg; liquicaps.
Procter & Gamble Pharmaceuticals
Indications for ZZZQUIL:
Relief of occasional sleeplessness.
50mg at bedtime as needed.
Asthma. Emphysema. Chronic bronchitis. Glaucoma. Cardiovascular disease. GI or GU obstruction. Reevaluate if no response or symptoms persist after 2 weeks. Pregnancy. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant other diphenhydramine products (including topicals): not recommended. Additive effects with other antihistamines, anticholinergics, sedatives, tranquilizers or other nighttime cold/fu products (eg, NyQuil); avoid.
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
Liquicaps—12, 24, 48; Liq—6oz, 12oz
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients
- Changes in Renal Cell Carcinoma Pathologic Staging and Histologic Grading
- Nocturia, Overactive Bladder Improved With PTNS
- Many Americans Unaware of Promise of Personalized Medicine
- Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk
- VDRAs Do Not Lower Cardiovascular Event Risk in HD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)